{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:39:53Z","timestamp":1791283193693,"version":"4.1.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1086\/313843","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:58:36Z","timestamp":1027709916000},"page":"S5-S14","source":"Crossref","is-referenced-by-count":530,"title":["Epidemiology of Human Immunodeficiency Virus\u2013Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy"],"prefix":"10.1093","volume":"30","author":[{"given":"Jonathan\u00a0E.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00a0S.","family":"Dworkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Bertolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary\u00a0Lou","family":"Lindegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey\u00a0L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"rf1_3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"rf2_4","first-page":"165","volume":"46","author":"Centers","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"rf3_5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1086\/515030","volume":"27","author":"Forrest DM","year":"1998","journal-title":"Clin Infect Dis"},{"key":"rf4_6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03201-2"},{"key":"rf5_7","unstructured":"Torres RA, Baney M, Barr MR. Stabilization of in-patient daily census despite continued reduction in HIV-related admissions at a New York City hospital [abstract 203]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1998:117."},{"key":"rf6_8","first-page":"57","volume":"1","author":"Jahnke N","year":"1999","journal-title":"AIDS Rev"},{"key":"rf7_9","doi-asserted-by":"publisher","DOI":"10.1086\/313848"},{"key":"rf8_10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.267.13.1798"},{"key":"rf9_11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/oxfordjournals.aje.a116691","volume":"137","author":"Munoz A","year":"1993","journal-title":"Am J Epidemiol"},{"key":"rf10_12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-124-7-199604010-00003","volume":"124","author":"Moore RD","year":"1996","journal-title":"Ann Intern Med"},{"key":"rf11_13","first-page":"1","volume":"48","author":"Jones JL","year":"1999","journal-title":"In: CDC Surveillance Summaries. MMWR Morb Mortal Wkly Rep"},{"key":"rf12_14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/515593","volume":"178","author":"Jones JL","year":"1998","journal-title":"J Infect Dis"},{"key":"rf13_15","unstructured":"Murphy R, El-Sadr W, Cheung T, etal Impact of protease inhibitor containing regimens on the risk of developing opportunistic infections and mortality in the CPCRA 034\/ACTG 277 study [abstract 181]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1998:113."},{"key":"rf14_16","unstructured":"Currier JS, Williams PL, Grimes JM, etal Incidence rates and risk factors for opportunistic infections in a phase III trial comparing indinavir + ZDV + 3TC to ZDV + 3TC [abstract 257]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1998:127."},{"key":"rf15_17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07204-3"},{"key":"rf16_18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03287-0"},{"key":"rf17_19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904293401701"},{"key":"rf18_20","unstructured":"Yangco BG, von Bargen JC, Moorman AC, Ragland KM, Holmberg SD. Can PCP prophylaxis be safely discontinued among clinically improving HIV patients? [abstract I-262]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1998:446."},{"key":"rf19_21","unstructured":"Lopez JC, Miro JM, Pena JM, Podzamczer D. Discontinuation of PCP prophylaxis is safe in HIV-infected patients after immunologic recovery with HAART: results of the Gesida 04\/98 study [abstract LB-24]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (addendum). Washington, DC: American Society for Microbiology, 1999:19."},{"key":"rf20_22","unstructured":"Antinori A, Borghi V, Concia B, etal An open controlled randomized trial on the discontinuation of primary PCP prophylaxis among HIV-infected individuals whose CD4 count returned to a level greater than 200 cells\/mm3 after HAART: CIOP study [abstract 1165]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1999:492."},{"key":"rf21_23","unstructured":"Dworkin M, Hanson D, Jones J, Kaplan J. The risk for Pneumocystis carinii pneumonia (PCP) and disseminated nontuberculous mycobacteriosis (dMb) after an antiretroviral therapy (ART) associated increase in the CD4+ T-lymphocyte count [abstract 692]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1999:198."},{"key":"rf22_24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/infdis\/168.1.61","volume":"168","author":"Fleming PL","year":"1993","journal-title":"J Infect Dis"},{"key":"rf23_25","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199510000-00005"},{"key":"rf24_26","doi-asserted-by":"publisher","DOI":"10.1086\/313841"},{"key":"rf25_27","unstructured":"Jones J, Hanson D, Dworkin M, Kaplan J. Which opportunistic illnesses occur in the era of HAART and at what CD4 cell counts? [abstract 690]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1999:198."},{"key":"rf26_28","unstructured":"Currier JS, Williams PL, Koletar S, etal A randomized placebo-controlled trial of azithromycin prophylaxis for the prevention of Mycobacterium avium complex (MAC) in subjects with increases in CD4 cells on antiretroviral therapy [abstract LB-23]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy [addendum]. Washington, DC: American Society for Microbiology 1999:19."},{"key":"rf27_29","first-page":"257","author":"Kaplan JE","year":"1998","journal-title":"DC: American Society for Microbiology"},{"key":"rf28_30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.276.2.126"},{"key":"rf29_31","unstructured":"Sweeney PA, Fleming PL, Karon JM, Ward JW. A minimum estimate of the number of living HIV infected persons confidentially tested in the United States [abstract I-16]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1997:245."},{"key":"rf30_32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812243392606"},{"key":"rf31_33","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/515658","volume":"178","author":"Kaplan JE","year":"1998","journal-title":"J Infect Dis"},{"key":"rf32_34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0749-3797(18)30577-4","volume":"10","author":"Glassroth J","year":"1994","journal-title":"Am J Prev Med"},{"key":"rf33_35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403173301107"},{"key":"rf34_36","first-page":"527","volume":"29","author":"Fleishman JA","year":"1994","journal-title":"Health Serv Res"},{"key":"rf35_37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00126334-199907010-00008","volume":"21","author":"Kaplan JE","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf36_38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.24.2305"},{"key":"rf37_39","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199909100-00012"},{"key":"rf38_40","first-page":"1","volume":"47","author":"Centers","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"rf39_41","first-page":"1","volume":"44","author":"Centers","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"rf40_42","unstructured":"Lindegren ML, Byers B, Rogers M, Wortley P, Fleming P. On the verge of elimination of perinatally acquired HIV\/AIDS? Updated trends in HIV\/AIDS in the United States [abstract 228]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1999:111."},{"key":"rf41_43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1542\/peds.97.5.710","volume":"97","author":"Barnhart HX","year":"1996","journal-title":"Pediatrics"},{"key":"rf42_44","first-page":"1","volume":"47","author":"Centers","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"rf43_45","unstructured":"Centers for Disease Control and Prevention. HIV\/AIDS surveillance report 1998; 10:1-43."},{"key":"rf44_46","unstructured":"Deeks SG, Loftus R, Cohen P, Chin S, Grant R. Incidence and predictors of virologic failure to indinavir and\/or ritonavir in an urban health clinic [abstract LB-2]. In: abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1997."},{"key":"rf45_47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.24.1984"},{"key":"rf46_48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390504"},{"key":"rf47_49","unstructured":"Centers for Disease Control and Prevention. HIV\/AIDS surveillance report 1999; 11:1-42."},{"key":"rf48_50","unstructured":"Palella F, Moorman A, Chmiel J, etal, and the HIV Outpatient Study (HOPS) Investigators. Continued decline in morbidity and mortality among patients with advanced HIV infection receiving highly active antiretroviral therapy (HAART) [abstract 689]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1999:197."},{"key":"rf49_51","unstructured":"Paul S, Ziecheck W, Gilbert HM, Jacobs J, Sepkowitz KA. Impact of HAART on rates and types of hospitalization at a New York City hospital [abstract 205]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1998:117."},{"key":"rf50_52","unstructured":"Perez-Olmeda M, Machuca A, Garcia-Samaniego J, Soriano V. HAART does not modify HCV replication in HIV-HCV co-infected patients [abstract 193]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1999:104."},{"key":"rf51_53","unstructured":"Puoti M, Bonacini M, Govindarajan S, etal Liver fibrosis progression in patients with hepatitis C and HIV infection [abstract 190]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1999:103."},{"key":"rf52_54","unstructured":"Tor J, Tural C, Ojanguren I, etal Histological damage of hepatitis C in HIV-infected patients [abstract 192]. In: Program and abstracts of the 6th Conference on Retrovirology and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 1999:104."},{"key":"rf53_55","first-page":"S11","volume":"21","author":"Jones JL","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf54_56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11431-8"},{"key":"rf55_57","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04352-3"},{"key":"rf56_58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","volume":"158","author":"Narita M","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"rf57_59","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199812000-00011"},{"key":"rf58_60","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199814000-00013"},{"key":"rf59_61","unstructured":"Phillips P, Yip B, Hogg R, etal Azithromycin (AZM) for M. avium complex (MAC) prophylaxis in HIV patients during the HAART era: evaluation of a provincial program [abstract 132]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1999:457."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/30\/Supplement_1\/S5\/17848847\/30-Supplement_1-S5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T01:17:16Z","timestamp":1682212636000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/313843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":59,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1086\/313843"],"URL":"https:\/\/doi.org\/10.1086\/313843","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}